5 results on '"Pastuszak, Krzysztof"'
Search Results
2. Improving platelet‐RNA‐based diagnostics: a comparative analysis of machine learning models for cancer detection and multiclass classification.
- Author
-
Jopek, Maksym A., Pastuszak, Krzysztof, Sieczczyński, Michał, Cygert, Sebastian, Żaczek, Anna J., Rondina, Matthew T., and Supernat, Anna
- Abstract
Liquid biopsy demonstrates excellent potential in patient management by providing a minimally invasive and cost‐effective approach to detecting and monitoring cancer, even at its early stages. Due to the complexity of liquid biopsy data, machine‐learning techniques are increasingly gaining attention in sample analysis, especially for multidimensional data such as RNA expression profiles. Yet, there is no agreement in the community on which methods are the most effective or how to process the data. To circumvent this, we performed a large‐scale study using various machine‐learning techniques. First, we took a closer look at existing datasets and filtered out some patients to assert data collection quality. The final data collection included platelet RNA samples acquired from 1397 cancer patients (17 types of cancer) and 354 asymptomatic, presumed healthy, donors. Then, we assessed an array of different machine‐learning models and techniques (e.g., feature selection of RNA transcripts) in pan‐cancer detection and multiclass classification. Our results show that simple logistic regression performs the best, reaching a 68% cancer detection rate at a 99% specificity level, and multiclass classification accuracy of 79.38% when distinguishing between five cancer types. In summary, by revisiting classical machine‐learning models, we have exceeded the previously used method by 5% and 9.65% in cancer detection and multiclass classification, respectively. To ease further research, we open‐source our code and data processing pipelines (https://gitlab.com/jopekmaksym/improving‐platelet‐rna‐based‐diagnostics), which we hope will serve the community as a strong baseline. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Platelet-Based Liquid Biopsies through the Lens of Machine Learning.
- Author
-
Cygert, Sebastian, Pastuszak, Krzysztof, Górski, Franciszek, Sieczczyński, Michał, Juszczyk, Piotr, Rutkowski, Antoni, Lewalski, Sebastian, Różański, Robert, Jopek, Maksym Albin, Jassem, Jacek, Czyżewski, Andrzej, Wurdinger, Thomas, Best, Myron G., Żaczek, Anna J., and Supernat, Anna
- Subjects
- *
SEQUENCE analysis , *BLOOD platelets , *MINIMALLY invasive procedures , *MACHINE learning , *BLOOD collection , *CANCER patients , *CELLULAR signal transduction , *ALGORITHMS ,BODY fluid examination - Abstract
Simple Summary: Liquid biopsies are a non-invasive way to diagnose and monitor cancer using blood tests. Machine learning can help understand the genetic data from these tests, but it is challenging to validate clinical applications. In our study, we first compiled a large-scale dataset for cancer classification. Then, we extracted relevant features from the data and performed a binary classification, with the prediction outcome of either a sample collected from a cancer patient or a sample collected from an asymptomatic control. We used different convolutional neural networks (CNNs) and boosting methods to evaluate the classification performance. We have obtained an impressive result of 0.96 area under the curve. Finally, we tested the robustness of the models using test data from novel hospitals and performed data inspection to find the most relevant features for the prediction. Our work proves the great potential of using liquid biopsies for cancer patient classification. Liquid biopsies offer minimally invasive diagnosis and monitoring of cancer disease. This biosource is often analyzed using sequencing, which generates highly complex data that can be used using machine learning tools. Nevertheless, validating the clinical applications of such methods is challenging. It requires: (a) using data from many patients; (b) verifying potential bias concerning sample collection; and (c) adding interpretability to the model. In this work, we have used RNA sequencing data of tumor-educated platelets (TEPs) and performed a binary classification (cancer vs. no-cancer). First, we compiled a large-scale dataset with more than a thousand donors. Further, we used different convolutional neural networks (CNNs) and boosting methods to evaluate the classifier performance. We have obtained an impressive result of 0.96 area under the curve. We then identified different clusters of splice variants using expert knowledge from the Kyoto Encyclopedia of Genes and Genomes (KEGG). Employing boosting algorithms, we identified the features with the highest predictive power. Finally, we tested the robustness of the models using test data from novel hospitals. Notably, we did not observe any decrease in model performance. Our work proves the great potential of using TEP data for cancer patient classification and opens the avenue for profound cancer diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnostics.
- Author
-
Pastuszak, Krzysztof, Supernat, Anna, Best, Myron G., In't Veld, Sjors G. J. G., Łapińska-Szumczyk, Sylwia, Łojkowska, Anna, Różański, Robert, Żaczek, Anna J., Jassem, Jacek, Würdinger, Thomas, and Stokowy, Tomasz
- Abstract
Liquid biopsies offer a minimally invasive sample collection, outperforming traditional biopsies employed for cancer evaluation. The widely used material is blood, which is the source of tumor-educated platelets. Here, we developed the imPlatelet classifier, which converts RNA-sequenced platelet data into images in which each pixel corresponds to the expression level of a certain gene. Biological knowledge from the Kyoto Encyclopedia of Genes and Genomes was also implemented to improve accuracy. Images obtained from samples can then be compared against standard images for specific cancers to determine a diagnosis. We tested imPlatelet on a cohort of 401 non-small cell lung cancer patients, 62 sarcoma patients, and 28 ovarian cancer patients. imPlatelet provided excellent discrimination between lung cancer cases and healthy controls, with accuracy equal to 1 in the independent dataset. When discriminating between noncancer cases and sarcoma or ovarian cancer patients, accuracy equaled 0.91 or 0.95, respectively, in the independent datasets. According to our knowledge, this is the first study implementing an image-based deep-learning approach combined with biological knowledge to classify human samples. The performance of imPlatelet considerably exceeds previously published methods and our own alternative attempts of sample discrimination. We show that the deep-learning image-based classifier accurately identifies cancer, even when a limited number of samples are available. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer.
- Author
-
Łukasiewicz, Marta, Pastuszak, Krzysztof, Łapińska-Szumczyk, Sylwia, Różański, Robert, Veld, Sjors G. J. G. In 't, Bieńkowski, Michał, Stokowy, Tomasz, Ratajska, Magdalena, Best, Myron G., Würdinger, Thomas, Żaczek, Anna J., Supernat, Anna, and Jassem, Jacek
- Subjects
- *
PREOPERATIVE care , *SEQUENCE analysis , *DNA , *BLOOD platelets , *ENDOSCOPIC surgery , *RNA , *ARTIFICIAL intelligence , *DIFFERENTIAL diagnosis , *ENDOMETRIAL tumors , *DESCRIPTIVE statistics , *EXTRACELLULAR space , *TUMOR markers , *NUCLEIC acids , *FEMALE reproductive organ tumors , *BLOOD ,BODY fluid examination - Abstract
Simple Summary: The number of endometrial cancer (EC) cases is constantly growing. However, the current diagnostic approach is still rather imprecise, leaving 1/3 of patients temporarily undiagnosed. Moreover, final diagnosis is made after the surgery. That mean the histology of tumor, which influences scope of resection, is uncertain during procedure. This results in over- and undertreatment of EC patients. Those diagnostic problems might be solved by liquid biopsy—a new, minimally invasive method to obtain tumor biomarkers. Therefore, this study aimed to evaluate the usefulness of information obtained from liquid biopsy components (tumor educated platelets and circulating tumor DNA) coupled with random forest algorithm and deep neural networks to diagnose EC patients and evaluate tumor histology preoperatively. Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor educated platelets (TEPs) and circulating tumor DNA (ctDNA) for preoperative EC diagnosis, including histology determination. Methods: TEPs from 295 subjects (53 EC patients, 38 patients with benign gynecologic conditions, and 204 healthy women) were RNA-sequenced. DNA sequencing data were obtained for 519 primary tumor tissues and 16 plasma samples. Artificial intelligence was applied to sample classification. Results: Platelet-dedicated classifier yielded AUC of 97.5% in the test set when discriminating between healthy subjects and cancer patients. However, the discrimination between endometrial cancer and benign gynecologic conditions was more challenging, with AUC of 84.1%. ctDNA-dedicated classifier discriminated primary tumor tissue samples with AUC of 96% and ctDNA blood samples with AUC of 69.8%. Conclusions: Liquid biopsies show potential in EC diagnosis. Both TEPs and ctDNA profiles coupled with artificial intelligence constitute a source of useful information. Further work involving more cases is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.